Records 1-30 (of 31 Records) |
Query Trace: Precision public health[original query] |
---|
Application of phylodynamic tools to inform the public health response to COVID-19: a qualitative analysis of expert opinions. Shannan Nicole Rich et al. JMIR formative research 2023 2 |
Precision public-health intervention for care coordination: a real-world study. Andrade Andre Q, et al. The British journal of general practice : the journal of the Royal College of General Practitioners 2023 0 0. (728) e220-e230 |
Genomic analysis of SARS-CoV-2 variants of concern circulating in Hawai'i to facilitate public-health policies. Maison David P, et al. PloS one 2022 0 0. (12) e0278287 |
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection. Arriaga-Canon Cristian, et al. International journal of molecular sciences 2022 0 0. (19) |
Intelligent risk prediction in public health using wearable device data MM Raza et al, NPJ Digital Medicine, October 13, 2022
A recent study found that machine learning can predict the risk of COVID-19 infection, by combining biometric data from wearable devices like Fitbit, with electronic symptom surveys. In doing so, they aim to increase the efficiency of test allocation when tracking disease spread in resource-limited settings. But the implications of technology that applies data from wearables stretch far beyond infection monitoring into healthcare delivery and research. The adoption and implementation of this type of technology will depend on regulation, impact on patient outcomes, and cost savings.
|
The Lancet Summit: Big data and AI in pandemic preparedness October 27-28, 2022, online
Managing COVID-19 and infectious disease is a global priority over the next few decades. Clinical and research communities are committed to reviewing the global response to the COVID-19 pandemic and a key part has been the unprecedented use and rapid scale of technology. This conference will allow diverse stakeholders to discuss opportunities for new pandemic warning systems based on modelling approaches using AI; advances in real-world surveillance and tracking of disease spread; AI for drug screening and rapid diagnostics; and advances in remote treatment and telehealth.
|
Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai'i to Facilitate Public-Health Policies. Maison David P, et al. Research square 2022 0 0. |
Host Genomics and COVID-19: Implications for Clinical and Public Health Practice CDC Precision Public Health Webinar, October 6, 2022
This seminar will review our emerging knowledge of the role of host genomic factors in the susceptibility and outcomes of COVID-19 infection, response to vaccines and treatments as well as long-term sequels of the disease. Our speakers will discuss implications of such knowledge for clinical and public health practice and how this information could be used in the control of the pandemic, and more generally in the control of infectious diseases.
|
Colliding with Collider Bias: Implications for Precision Public Health D Rasooly et al, CDC Blog Post, May 9, 2022
Large-scale genomic studies have uncovered thousands of statistical associations between genetic variants and health outcomes, transforming our understanding of the genetic determinants of human diseases. Nevertheless, study sample selection and attrition over time can bias associations between variables, generating potentially biased estimates for genetic associations. This bias can be magnified in the case of studying phenotypic associations with polygenic risk scores in large scale cohort studies of unrepresentative or highly selected populations, such as the UK biobank, and potentially in the newly launched All of Us Research Program cohort study.
|
COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. Yu Wei et al. BMC infectious diseases 2022 4 (1) 402 |
COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response W Yu et al, BMC Infectious Diseases, April 25, 2022
To quantify and track the ongoing contributions of genomics and precision health to the COVID-19 response, the Office of Genomics and Precision Public Health at the Centers for Disease Control and Prevention created the COVID-19 Genomics and Precision Health database (COVID-19 GPH), an open access knowledge management system and publications database that is continuously updated through machine learning and manual curation.
This unique knowledge management database makes it easier to explore, describe, and track how the pandemic response is accelerating the applications of genomics and precision health technologies.
|
Precision Public Health and Structural Racism in the United States: promoting health equity in the COVID-19 pandemic response. Geneviève Lester Darryl, et al. JMIR public health and surveillance 2022 0 0. |
Precision Public Health in the Pandemic: Using MicrobeTrace to Track COVID-19 - Introduction Slides, May 26, 2021 - CDC Webinar |
Mendelian Randomization: A Precision Public Health Tool for the COVID-19 Response E Drzymalla et al, CDC Blog, July 20, 2021
In the early days of the COVID-19 pandemic, when little was known about the natural history of the disease, predicting the course of the pandemic was of premier importance for treating sick patients and redoubling efforts to protect those at highest risk of adverse outcomes. To address this need, investigators used a study design that is rooted in human genetics, Mendelian randomization, an approach that has been used to identify important modifiable risk factors for common chronic diseases.
|
Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai’i to Facilitate Public-Health Policies Maison, David P et al. Research Square June 09 2021 |
The impact of genomics on precision public health: beyond the pandemic. Khoury Muin J et al. Genome medicine 2021 4 (1) 67
As the COVID-19 pandemic clearly shows, we need the tools of genomics more than ever before in the fight against infectious diseases. Beyond fighting outbreaks, genomics will become an essential component of public health in the twenty-first century for communicable and noncommunicable diseases.
|
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality. Alghamdi Jahad, et al. Genomics 2021 4 0. |
mRNA COVID-19 Vaccines: An Incredible Feat of Genomic Technology (blog post) Cono J, et al. Office of Genomics and Precision Public Health/OS/CDC, Mar 5, 2021. |
Research Methodology to Define the Introduction of the SARS-CoV-2 B.1.429 Variant in Hawaii. Maison David P, et al. Research square 2021 4 0. |
Increasing Uptake of Social Distancing during COVID-19: Machine Learning Strategies for Targeted Interventions Charles, Grace et al. SSRN May 15 2020 |
The Public Health Impact of COVID-19: Why Host Genomics? (blog post) Khoury M, et al. Office of Genomics and Precision Public Health, OS, CDC. Apr 21, 2020. |
Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era. Juengst Eric T et al. Genome medicine 2020 Nov (1) 98 |
Precision Public Health as a Key Tool in the COVID-19 Response. Rasmussen Sonja A et al. JAMA 2020 8 (10) 933-934
The COVID-19 pandemic provides an opportunity for further evolution of the field of precision public health, as new tools and technologies begin to complement traditional medical and public health approaches to prevention and control. Despite challenges, at no time has precision public health been needed more than now.
|
COVID-19 and School Closures. Donohue Julie M et al. JAMA 2020 8 (9) 845-847
A precision public health approach means having easy access to real-time data to evaluate the effectiveness of specific approaches and adjust accordingly. A precision public health approach also benefits from strong collaborations. School nurses, administrators, parents, and educators need to perceive data and experts interpreting these data as trustworthy.
|
In the Era of Public Health Emergencies, Interoperability Rules are a Beacon for More Precision in Public Health P Braun, March 30, 2020 |
The Public Health Impact of COVID-19: Why Host Genomics? MJ Khoury el al, CDC Blog, April 21, 2020 |
Precision Public Health in the Pandemic- Using MicrobeTrace to Track COVID-19 CDC May 26 webinar |
Using Digital Technologies in Precision Public Health: COVID-19 and Beyond MJ Khoury et al, CDC Blog, April 2020 |
Applications of Digital Tools for Precision Public Health in the COVID-19 Era: Where Are We? M Khoury et al, CDC Blog, March 29, 2021 |
COVID-19 Genomics and Precision Public Health Weekly Update CDC, August 2020 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source: